Type 2 Diabetes — NZ Condition Guide | KiwiMeds

What is Type 2 Diabetes?

Type 2 diabetes is a long-term condition where your body does not use insulin properly, causing blood sugar levels to become too high. It is the most common form of diabetes in New Zealand, affecting around 250,000 New Zealanders. Unlike type 1 diabetes, type 2 is largely related to lifestyle factors, though genetics also play a role.

Symptoms

Many people with type 2 diabetes have no symptoms at first, which is why regular screening is important. When symptoms do occur, they can include increased thirst and urination, fatigue, blurred vision, slow-healing cuts or sores, frequent infections, tingling or numbness in hands and feet, and unexplained weight loss. Because symptoms develop gradually, type 2 diabetes is often discovered during a routine blood test.

Causes and Risk Factors

Type 2 diabetes develops when your cells become resistant to insulin, or your pancreas cannot make enough insulin to keep blood sugar normal. Risk factors include being overweight or obese (especially around the abdomen), physical inactivity, family history of diabetes, age over 40, having prediabetes, high blood pressure, high cholesterol, and certain ethnic backgrounds — Māori, Pacific, and South Asian people have a higher risk of type 2 diabetes in NZ.

Diagnosis

Type 2 diabetes is diagnosed with blood tests. Your GP will usually check your HbA1c (a measure of average blood sugar over 3 months) and/or a fasting blood glucose test. An HbA1c of 50 mmol/mol or above is diagnostic for diabetes. If you are at risk, your GP may screen you even if you have no symptoms. Early detection is important because treatment can prevent or delay serious complications.

Treatment Options in New Zealand

Treatment for type 2 diabetes in NZ usually starts with lifestyle changes — healthy eating, regular physical activity, and losing weight if needed. If lifestyle changes are not enough, your GP will prescribe medicines. Metformin is the most commonly prescribed first-line medication — it is Pharmac-funded and very affordable at the standard $5 prescription charge. Other Pharmac-funded options include gliclazide, pioglitazone, and insulin. Newer medicines like SGLT2 inhibitors (empagliflozin, dapagliflozin) and GLP-1 agonists (semaglutide/Ozempic) are also funded for people with type 2 diabetes who meet certain criteria. Diabetes NZ and your local DHB/Te Whatu Ora provide free diabetes education programmes.

NZ-Specific Information

New Zealand has one of the highest rates of type 2 diabetes in the developed world, particularly among Māori and Pacific peoples. The New Zealand Diabetes Action Plan and the Primary Health Organisation (PHO) provide funded screening and monitoring for people with diabetes. Most diabetes medications are fully funded on the Pharmac schedule with a standard $5 prescription charge. Living Well with Diabetes is a free NZ online programme. You can also access free dietitian support through your GP referral.

Frequently Asked Questions

Can type 2 diabetes be reversed? For some people, yes — particularly with significant weight loss and lifestyle changes, some people achieve blood sugar levels in the normal range without medication. However, the underlying tendency remains, so maintaining healthy habits is essential. Do I need insulin? Not necessarily. Many people manage type 2 diabetes with tablets alone. Insulin may be needed if other medicines are not controlling blood sugar adequately. Can I still eat carbohydrates? Yes, but the type and amount matters. A dietitian can help you find an eating pattern that keeps your blood sugar stable.

Supplements That May Support Management

⚠️ Important: The supplements listed below have varying levels of clinical evidence. They are not a substitute for prescribed medications and should only be considered as adjunctive support under the guidance of a qualified healthcare professional. Always inform your GP or pharmacist before commencing any supplement, as interactions with prescribed medicines are possible.

• Magnesium — Magnesium deficiency is prevalent in people with type 2 diabetes. Supplementation may improve insulin sensitivity and glycaemic control, particularly in those with documented hypomagnesaemia. Typical dose: 200–400 mg daily.
• Vitamin D — Emerging evidence suggests vitamin D deficiency is associated with impaired insulin secretion and increased insulin resistance. Supplementation is advised where deficiency is confirmed on blood testing.
• Berberine — Berberine, a plant-derived alkaloid, has demonstrated clinically meaningful reductions in fasting glucose and HbA1c in several randomised controlled trials, acting via AMPK activation. It should be used with caution alongside glucose-lowering medications due to additive hypoglycaemic risk.
• Alpha-Lipoic Acid (ALA) — ALA is an antioxidant with evidence supporting improvement in peripheral insulin sensitivity and potential benefit in diabetic peripheral neuropathy at doses of 600–1200 mg daily.
• Chromium Picolinate — Chromium is an essential trace mineral involved in insulin signalling. Supplementation at 200–1000 mcg daily may modestly improve glucose tolerance, though evidence is of variable quality.

Relevant Vaccinations

Individuals living with type 2 diabetes may benefit from the following vaccinations. Please discuss your vaccination status with your GP or practice nurse, as eligibility and funding through the New Zealand National Immunisation Schedule may apply.

• Influenza (annual) — People with type 2 diabetes are at significantly increased risk of influenza-related complications, including hospitalisation and deterioration in glycaemic control. Annual influenza vaccination is strongly recommended and is funded under the NZ National Immunisation Schedule.
• Pneumococcal (PCV20 or PPSV23) — Diabetes increases susceptibility to pneumococcal disease. Pneumococcal vaccination is recommended and funded for people with diabetes in NZ.
• COVID-19 (booster doses) — People with diabetes are at higher risk of severe COVID-19 disease. Up-to-date COVID-19 vaccination, including recommended booster doses, is advised.
• Hepatitis B — Hepatitis B vaccination is recommended for adults with diabetes who have not been previously immunised, due to risk of transmission from shared glucose monitoring equipment.

Dietary Guidance

Evidence-based dietary modifications play a meaningful role in the management of type 2 diabetes. The following foods are generally recommended as part of a balanced, condition-appropriate diet. A referral to a registered dietitian may be beneficial for personalised nutritional planning.

• Non-starchy vegetables (broccoli, spinach, capsicum) — High in fibre and micronutrients with minimal glycaemic impact. Regular consumption supports blood glucose stability and cardiovascular health.
• Legumes (lentils, chickpeas, kidney beans) — Low glycaemic index foods that slow carbohydrate absorption, improve post-prandial glucose response, and provide soluble fibre beneficial for cholesterol management.
• Oily fish (salmon, sardines, mackerel) — Rich in long-chain omega-3 fatty acids (EPA and DHA), which reduce cardiovascular risk — a major concern in type 2 diabetes. Aim for 2–3 servings per week.
• Whole grains (oats, barley, brown rice) — Provide sustained energy release with lower glycaemic impact compared to refined carbohydrates. The beta-glucan fibre in oats and barley also supports cholesterol reduction.
• Nuts and seeds (almonds, walnuts, chia seeds) — Rich in healthy unsaturated fats, protein, and fibre. Regular consumption is associated with improved glycaemic control and reduced cardiovascular risk.
• Berries (blueberries, raspberries, strawberries) — Low glycaemic index fruits rich in polyphenols and antioxidants, with evidence supporting improved insulin sensitivity and reduced oxidative stress.

Related Conditions & Medications

Related medications: Metformin. Related conditions: High Cholesterol, Hypertension.